Cytokinetics | CYTK - Selling And Administration Expenses

Stock Price
68.17
Daily Change
0.23 0.34%
Monthly
7.88%
Yearly
41.61%
Q1 Forecast
65.83

Cytokinetics reported $158.75M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Acadia Pharmaceuticals USD 124.9M 1.24M Sep/2025
Amgen USD 1.94B 237M Dec/2025
Arca Biopharma USD 5.16M 346K Mar/2025
Bayer EUR 3.4B 140M Sep/2025
Biogen USD 545.2M 38.6M Sep/2025
Brainstorm Cell Therapeutics USD 1.78M 319K Mar/2025
Bristol-Myers Squibb USD 2.18B 392M Dec/2025
Capricor Therapeutics USD 5.88M 1.6M Mar/2025
Cytokinetics USD 158.75M 93.03M Sep/2025
Eisai JPY 111.72B 7.86B Dec/2025
Eli Lilly USD 3.13B 391.3M Dec/2025
Exelixis USD 123.02M 19.9M Dec/2025
Geron USD 39M 437K Sep/2025
Halozyme Therapeutics USD 64.64M 27.11M Dec/2025
Ionis Pharmaceuticals USD 86.56M 4.04M Sep/2025
Ligand Pharmaceuticals USD 28.45M 8.27M Sep/2025
Merck USD 2.85B 215M Dec/2025
Novartis USD 3.31B 134M Sep/2025
Pfizer USD 4.08B 894M Dec/2025
Regeneron Pharmaceuticals USD 775M 117.2M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.75B 455M Dec/2025